Texas Administrative Code
Title 22 - EXAMINING BOARDS
Part 9 - TEXAS MEDICAL BOARD
Chapter 198 - STANDARDS FOR USE OF INVESTIGATIONAL AGENTS
Subchapter A - STANDARDS FOR USE OF INVESTIGATIONAL DRUGS, BIOLOGICAL PRODUCTS, OR DEVICES
Section 198.4 - Use of Investigational Drugs, Biological Products, or Devices for Patients with Terminal Illnesses

Universal Citation: 22 TX Admin Code § 198.4

Current through Reg. 49, No. 38; September 20, 2024

Investigational drugs, biological products, or devices which meet the criteria enumerated in § 198.2, of this title (relating to Definitions) and have successfully completed phase one of a clinical trial and remain under investigation in the clinical trial shall be administered and provided to patients with terminal illnesses in accordance with applicable law, including Chapter 489 of the Texas Health and Safety Code.

Disclaimer: These regulations may not be the most recent version. Texas may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.